Celldex Therapeutics, Inc.
CLDX
$18.30
$0.502.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.22% | 221.23% | 217.50% | 195.94% | 38.91% |
| Total Receivables | -73.36% | 238.10% | 1,200.00% | 103.27% | 657.35% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 287.38% | 112.82% | -32.33% | -11.00% | -55.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 73.08% | 216.69% | 206.61% | 188.44% | 35.88% |
|
|
|||||
| Total Current Assets | 73.08% | 216.69% | 206.61% | 188.44% | 35.88% |
| Net Property, Plant & Equipment | 24.21% | 5.32% | -12.23% | -18.38% | -14.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9,009.35% | 9,009.35% | 0.00% | 2.88% | 2.88% |
| Total Assets | 70.17% | 193.72% | 182.51% | 167.73% | 32.00% |
|
|
|||||
| Total Accounts Payable | -6.55% | -68.93% | 331.56% | -4.15% | 4.61% |
| Total Accrued Expenses | 53.62% | 52.69% | 51.70% | 87.07% | 71.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.04% | -10.86% | 3.86% | 10.11% | 11.70% |
| Total Finance Division Other Current Liabilities | -76.38% | -67.01% | 275.56% | 296.42% | 302.83% |
| Total Other Current Liabilities | -76.38% | -67.01% | 275.56% | 296.42% | 302.83% |
| Total Current Liabilities | 26.91% | 15.29% | 76.77% | 72.75% | 67.25% |
|
|
|||||
| Total Current Liabilities | 26.91% | 15.29% | 76.77% | 72.75% | 67.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 154.42% | 31.49% | -53.86% | -78.21% | -64.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.12% | -21.12% | -21.12% | -21.12% | -17.44% |
| Total Liabilities | 24.36% | 11.14% | 46.63% | 38.82% | 37.41% |
|
|
|||||
| Common Stock & APIC | 26.09% | 43.17% | 43.15% | 42.92% | 15.33% |
| Retained Earnings | -11.30% | -11.38% | -11.42% | -11.27% | -11.26% |
| Treasury Stock & Other | 0.18% | 147.68% | -14.09% | 5.70% | 162.54% |
| Total Common Equity | 74.06% | 218.54% | 193.17% | 177.01% | 31.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 74.06% | 218.54% | 193.17% | 177.01% | 31.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 74.06% | 218.54% | 193.17% | 177.01% | 31.57% |
|
|
|||||